First Trust Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.58M | Sell |
130,817
-53,569
| -29% | -$2.91M | ﹤0.01% | 1519 |
|
|
2026
Q1 | $11.6M | Buy |
184,386
+53,332
| +41% | +$4.27M | 0.01% | 1047 |
|
|
2025
Q4 | $12.5M | Sell |
131,054
-348,128
| -73% | -$34.1M | 0.01% | 1019 |
|
|
2025
Q3 | $46.8M | Buy |
479,182
+49,545
| +12% | +$5.13M | 0.03% | 594 |
|
|
2025
Q2 | $46.1M | Sell |
429,637
-188,265
| -30% | -$19M | 0.04% | 585 |
|
|
2025
Q1 | $62.3M | Buy |
617,902
+105,982
| +21% | +$10.7M | 0.06% | 453 |
|
|
2024
Q4 | $45.7M | Buy |
511,920
+315,708
| +161% | +$27.8M | 0.04% | 557 |
|
|
2024
Q3 | $16.4M | Sell |
196,212
-139,697
| -42% | -$11M | 0.02% | 891 |
|
|
2024
Q2 | $25.9M | Buy |
335,909
+242,140
| +258% | +$17.7M | 0.03% | 692 |
|
|
2024
Q1 | $6.42M | Sell |
93,769
-13,889
| -13% | -$893K | 0.01% | 1185 |
|
|
2023
Q4 | $6.22M | Sell |
107,658
-65,724
| -38% | -$3.51M | 0.01% | 1163 |
|
|
2023
Q3 | $9.15M | Sell |
173,382
-17,718
| -9% | -$929K | 0.01% | 1010 |
|
|
2023
Q2 | $10.3M | Buy |
+191,100
| New | +$9.98M | 0.01% | 1003 |
|
|
2022
Q3 | – | Sell |
-140,794
| Closed | -$5.25M | – | 2483 |
|
|
2022
Q2 | $5.25M | Sell |
140,794
-38,512
| -21% | -$1.57M | 0.01% | 1199 |
|
|
2022
Q1 | $7.94M | Buy |
179,306
+146,237
| +442% | +$6.34M | 0.01% | 1117 |
|
|
2021
Q4 | $1.41M | Sell |
33,069
-4,991
| -13% | -$210K | ﹤0.01% | 1932 |
|
|
2021
Q3 | $1.65M | Sell |
38,060
-130,613
| -77% | -$5.78M | ﹤0.01% | 1837 |
|
|
2021
Q2 | $7.21M | Sell |
168,673
-603,873
| -78% | -$25.4M | 0.01% | 1122 |
|
|
2021
Q1 | $29.9M | Sell |
772,546
-3,313,586
| -81% | -$125M | 0.04% | 571 |
|
|
2020
Q4 | $147M | Buy |
4,086,132
+3,523,734
| +627% | +$127M | 0.19% | 132 |
|
|
2020
Q3 | $21.5M | Buy |
562,398
+399,858
| +246% | +$15.4M | 0.03% | 519 |
|
|
2020
Q2 | $5.71M | Sell |
162,540
-109,611
| -40% | -$3.95M | 0.01% | 936 |
|
|
2020
Q1 | $8.88M | Sell |
272,151
-1,512,483
| -85% | -$59.1M | 0.02% | 681 |
|
|
2019
Q4 | $80.7M | Sell |
1,784,634
-22,140
| -1% | -$926K | 0.14% | 181 |
|
|
2019
Q3 | $73.5M | Buy |
1,806,774
+1,466,762
| +431% | +$62.1M | 0.14% | 185 |
|
|
2019
Q2 | $14.6M | Sell |
340,012
-1,048,160
| -76% | -$40.3M | 0.03% | 649 |
|
|
2019
Q1 | $53.3M | Buy |
1,388,172
+204,129
| +17% | +$7.8M | 0.11% | 238 |
|
|
2018
Q4 | $41.8M | Buy |
1,184,043
+346,861
| +41% | +$12.6M | 0.1% | 258 |
|
|
2018
Q3 | $32.2M | Buy |
837,182
+569,429
| +213% | +$19.9M | 0.06% | 390 |
|
|
2018
Q2 | $8.76M | Buy |
267,753
+248,695
| +1,305% | +$7.5M | 0.02% | 842 |
|
|
2018
Q1 | $521K | Sell |
19,058
-485,367
| -96% | -$13.2M | ﹤0.01% | 2010 |
|
|
2017
Q4 | $12.5M | Sell |
504,425
-331,971
| -40% | -$9.16M | 0.03% | 688 |
|
|
2017
Q3 | $24.4M | Sell |
836,396
-1,506
| -0.2% | -$41.6K | 0.06% | 403 |
|
|
2017
Q2 | $23.2M | Buy |
837,902
+659,255
| +369% | +$17.5M | 0.06% | 420 |
|
|
2017
Q1 | $4.44M | Sell |
178,647
-925,028
| -84% | -$22.5M | 0.01% | 1091 |
|
|
2016
Q4 | $23.9M | Sell |
1,103,675
-486,585
| -31% | -$10.6M | 0.07% | 378 |
|
|
2016
Q3 | $37.8M | Buy |
1,590,260
+620,330
| +64% | +$14.8M | 0.11% | 201 |
|
|
2016
Q2 | $22.7M | Sell |
969,930
-494,656
| -34% | -$10.7M | 0.07% | 362 |
|
|
2016
Q1 | $27.5M | Sell |
1,464,586
-591,506
| -29% | -$10.4M | 0.09% | 283 |
|
|
2015
Q4 | $37.9M | Sell |
2,056,092
-565,483
| -22% | -$10.1M | 0.1% | 221 |
|
|
2015
Q3 | $43M | Sell |
2,621,575
-2,161,388
| -45% | -$36.9M | 0.12% | 167 |
|
|
2015
Q2 | $84.7M | Buy |
4,782,963
+3,683,141
| +335% | +$65.8M | 0.22% | 95 |
|
|
2015
Q1 | $19.5M | Buy |
+1,099,822
| New | +$17.4M | 0.06% | 430 |
|
|
2014
Q3 | – | Sell |
-339,639
| Closed | -$4.34M | – | 2236 |
|
|
2014
Q2 | $4.34M | Buy |
339,639
+224,416
| +195% | +$2.92M | 0.02% | 1042 |
|
|
2014
Q1 | $1.56M | Sell |
115,223
-246,614
| -68% | -$3.24M | 0.01% | 1510 |
|
|
2013
Q4 | $4.35M | Sell |
361,837
-28,092
| -7% | -$332K | 0.02% | 1027 |
|
|
2013
Q3 | $4.58M | Buy |
389,929
+16,686
| +4% | +$180K | 0.02% | 932 |
|
|
2013
Q2 | $3.46M | Buy |
+373,243
| New | +$3.17M | 0.02% | 970 |
|
Other funds holding BSX
First Trust Advisors's BSX Position: Q2 2026 in Review
First Trust Advisors reduced its Boston Scientific (BSX) stake by 29% in Q2 2026, selling an estimated $2.91M and leaving 130,817 shares worth $5.58M. The position accounts for ﹤0.01% of the portfolio, ranked #1519.
First Trust Advisors first reported a position in BSX in Q2 2013 and has held it in 48 quarters since. The position peaked at $147M in Q4 2020. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- First Trust Advisors held 130,817 shares of Boston Scientific worth $5.58M as of Q2 2026.
- First Trust Advisors sold 53,569 Boston Scientific shares in Q2 2026, an estimated $2.91M.
- Boston Scientific made up ﹤0.01% of First Trust Advisors's portfolio in Q2 2026, its #1519 holding.
- First Trust Advisors first reported a position in Boston Scientific in Q2 2013 and has held it in 48 quarters since.
- First Trust Advisors's Boston Scientific position peaked at $147M in Q4 2020.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on First Trust Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.